World-class research. Ultimate impact.
More on impact ›
The section Genome Editing in Blood Disorders provides a platform for publishing the technological development and application of genome editing in blood diseases. This section publishes high-impact, peer-reviewed original research articles, methodology articles, rapid reports, commentary articles, and review articles in this area.
Gene Editing for the treatment of inherited and acquired blood disorders is a promising new approach which has the potential to provide lifelong correction of many debilitating diseases.
This section of the Frontiers in Genome Editing journal is focused on providing a platform for the publication of improvements in existing gene editing methods and for initial publication of novel gene editing methods for the treatment of blood disorders. Review articles will also be published; these reviews will play an important role in integrating the field, providing novel perspectives, and serving as educational materials for graduate and professional students, basic and physician scientists and physicians practicing in large and small communities world-wide.
A small sample of blood disorders, for which gene editing strategies will be published, include:
The ultimate goal is to provide a forum for the publication of gene editing approaches for blood disorders as these methods progress from basic science to clinical medicine.
Indexed in: coming soon
Genome Editing in Blood Disorders welcomes submissions of the following article types: Brief Research Report, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Specialty Grand Challenge.
All manuscripts must be submitted directly to the section Genome Editing in Blood Disorders, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Genome Editing in Blood Disorders will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Genome Editing.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com